Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis

Liver

Volumn 18, Issue 6, 1998, Pages 391-397

  Tordjmann, Thierry ^a,d   Soulie, Annie ^b   Guettier, Catherine ^a,c   Schmidt, Michel ^b   Berthou, Christian ^b   Beaugrand, Michel ^a   Sasportes, Marilyne ^b  

^a HÔPITAL JEAN VERDIER   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UFR Bobigny   (France)

^d INSERM   (France)

Author keywords

Chronic hepatitis; Granzyme B; Kupffer cells; Liver; Lymphocytotoxicity; Perforin

Indexed keywords

CD3 ANTIGEN; CD68 ANTIGEN; GRANZYME B; MESSENGER RNA; PERFORIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOLYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KUPFFER CELL; LIVER BIOPSY; LIVER CELL; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0031739327     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00823.x     Document Type: Article

References (38)

1. ROSSER B G, GORES G. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology 1995; 108: 252-75.
2. MIELI-VERGANI G, VERGANI D, JENKINS P J, et al. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg negative chronic active hepatitis. Clin Exp Immunol 1979; 38: 16-21.
3. LIAW Y F, LEE C S, TSAI S L, et al. T-cell mediated autologous hepatotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995; 22: 1368-73.
4. TAKAHASHI H, FUJIMOTO J, HANADA S, ISSELBACHER K J. Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc Natl Acad Sci USA 1995; 92: 1470-4.
5. KÄGI D, VIGNAUX F, LEDERMANN B, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528-30.
6. TSCHOPP J, NABHOLZ M. Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu Rev Immunol 1990; 8: 279-302.
7. SHRESTA S, MACIVOR D M, HEUSEL J W, RUSSEL J H, LEY T J. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci USA 1995; 92: 5679-83.
8. HEUSEL J W, WESSELSCHMIDT R L. SHRESTA S, RUSSEL J H, LEY T J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76: 977-87.
9. 2+-independant T cell-mediated cytotoxicity. J Exp Med 1993; 177: 195.
10. NAGATA S, GOLSTEIN P. The Fas death factor. Science 1996; 267: 1449-55.
11. HENKART P A. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1994; 1: 343-6.
12. OGASAWARA J, WATANABE-FUKANAGA R, ADACHI M, et al. Lethal effect of anti-Fas antibody in mice. Nature 1993; 364: 806-9.
13. GALLE P R, HOFMANN W J, WALCZACK H, et al. Involvement of CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223-30.
14. MITA E, HAYASHI N, LIO S, et al. Role of Fas ligand on apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994; 204: 468-74.
15. KONDO T, SUDA T, FUKUYAMA H, ADACHI M, NAGATA S. Essential roles of the Fas ligand in the development of hepatitis. Nat Med 1997; 3: 409-13.
16. WINWOOD P J, ARTHUR M J P. Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 1993; 13: 50-9.
17. DESMET V J, GERBER M, HOOFNAGGLE J H, MANNS M, SCHEUER P J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
18. JOHNSON P J, MCFARLANE I G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
19. KNODELL R G, ISHAK K G, BLACK W C, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
20. CLEMENT M-V. HADDAD P, SOULIÉ A, et al. Perforin and granzyme B as markers for acute rejection in heart transplantation. Immunology 1991; 3: 1175.
21. + peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor. Blood 1995; 86: 3500-6.
22. HOEFLER H, CHILDERS H, MONTMINY M R, GOODMAN R H, WOLFE J. In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem J 1986; 18: 3.
23. HATA K, VAN THIEL D H, HERBERMAN R B, WHITESIDE T L. Phenotypic and functional caracteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. Hepatology 1992; 15: 816-23.
24. MOSNIER J F, DEGOTT C, MARCELLIN P, HÉNIN D, ERLINGER S, BENHAMOU J P. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology 1993; 17: 366-71.
25. HASHIMOTO E, LINDOR K D, HOMBURGER H A, et al. Immunohistochemical characterisation of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clinic Proc 1993; 68: 1049-55.
26. NAKAMOTO Y, GUIDOTTI L G, CHISARI F V. CTL-induced liver disease requires co-stimulation of both the Fas ligand- and perforin-activated death pathways (abstract). Hepatology 1996; 24: 351A.
27. OKAZAKI M, HINO K, FUJII K, et al. Immunohistochemical study of Fas antigen in liver of patients with chronic hepatitis and autoimmune liver disease. Int Hepatol Commun 1995; 3: 285-9.
28. HIRAMATSU N, HAYASCHI N, KATAYAMA K, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis. Hepatology 1994; 19: 1354-9.
29. YOUNG L H Y, JOAG S V, ZHENG L-M, LEE C-P, LEE Y-S, YOUNG J D-E. Perforin-mediated myocardial damage in acute myocarditis. Lancet 1990; 336: 1019-21.
30. GOEBELS N, MICHAELIS D, ENGELHARDT M, et al. Differential expression of perform m muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996; 12: 2905-10.
31. LEGROS-MAÏDA S, SOULIÉ A, BENVENUTI C, et al. Granzyme B and perform can be used as predictive markers of acute rejection in heart transplantation. Eur J Immunol 1994; 24: 229-33.
32. CLÉMENT M V, LEGROS-MAÏDA S, ISRAËL-BIET D, et al. Perform and granzyme B expression is associated with severe acute rejection. Transplantation 1994; 57: 322-6.
33. MARTIN A R, CHAN W C, PERRY D A, GREINER T C, WEISENBURGER D D. Aggressive natural killer cell lymphoma of the small intestine. Mod Pathol 1995; 8: 467-72.
34. MÜLLER C, KÄGGI D, AEBISCHER T, et al. Detection of perform and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur J Immunol 1989; 19: 1253-9.
35. KÄGI D, HENGARTNER H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus non-cytopathic viruses. Curr Opin Immunol 1996; 8: 472-7.
36. TOTH C A, THOMAS P. Liver endocytosis and Kupffer cells. Hepatology 1992: 16: 255-66.
37. DECKER K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990; 192: 245-61.
38. BERTHOC C, MICHEL L, SOULIÉ A, et al. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. J Immunol 1997; 159: 5293-300.